How metabolites affect immune cells in colorectal cancer
Metabolites regulating macrophage function in colorectal cancer
This study is looking at how certain substances in colorectal cancer tumors affect immune cells, especially those that help fight off cancer, to find new ways to boost the immune system in patients with this type of cancer.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10875586 on NIH RePORTER |
What this research studies
This research investigates how specific metabolites found in colorectal cancer (CRC) tumors influence the behavior of immune cells, particularly macrophages. By analyzing tumor samples, the study aims to understand how these metabolites can create an immune-suppressive environment that hinders effective immune responses. The researchers will explore the relationship between these metabolites and the polarization of macrophages, which may lead to new therapeutic strategies that enhance immune responses in CRC patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with colorectal cancer who may not be responding to current immune therapies.
Not a fit: Patients with colorectal cancer who have already shown a strong response to immune checkpoint inhibitors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve immune responses in colorectal cancer patients, potentially enhancing the effectiveness of existing therapies.
How similar studies have performed: Previous research has indicated that targeting the tumor microenvironment can improve immune responses, suggesting that this approach may hold promise.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Subramanian, Subbaya — University of Minnesota
- Study coordinator: Subramanian, Subbaya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.